WHO ICTRP trial
Efficacy of Esomeprazole in Children and Adolescents With Autism Spectrum…
NCT03669159 · NIH Clinical Trials · Recruiting
Key facts
| Trial ID | NCT03669159 |
|---|---|
| Public title | Efficacy of Esomeprazole in Children and Adolescents With Autism Spectrum Disorder |
| Scientific title | Efficacy of Esomeprazole in Children and Adolescents With Autism Spectrum Disorder |
| Primary sponsor | National Taiwan University Hospital |
| Registry | NIH Clinical Trials |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Taiwan |
| Conditions | Autism Spectrum Disorder |
| Interventions | Drug: Nexium;Drug: Placebo |
| Registration date | Feb 20, 2018 |
| Target size | 90 |
| Secondary IDs | 201705141MIND |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: